Dying for Some Standards: Broken Medical Systems as Revealed by a New FDA Warning

March 21, 2011

’d like to say I was shocked when a colleague sent me the warning letter from Eli Lilly relaying results of a French study that seem to indicate a 30 percent increased risk of death among children treated with recombinant human growth hormone (rhGH) in attempts to make them taller. (Bioethics Forum)